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Chloroform in water is a by-product ofthe
chlorination process (1). Bathing orshower-
ing in chlorinated tap water exposes indi-
viduals to chloroform by ingestion, inhala-
tion, or dermal contact. Some epidemiolog-
ical studies have suggested that exposure to
chlorinated water causes bladder cancer
(2-4) and is associated with rectal cancer
(4) and potential birth defects (5).
Several studies, including some based on
exhaled breath analysis, suggest that signifi-
cant dermal exposure to chloroform occurs
while showering, and the dose is roughly
comparable to that resulting from inhalation
(6-9). More recent studies have extended
this work to swimming in indoor pools
(10-14). Most of these investigations have
used breath measurements to determine
total exposure. Because ofthe dynamic equi-
librium between the concentration of a
volatile organic compounds (VOCs) in the
blood and their concentration in exhaled
breath (15), breath measurements can be
used to estimate body burden and to detect
changes in body burdenwith time (16-19).
An important question concerns the rel-
ative contribution of dermal exposure to
total exposure during showers and baths. It
has been difficult to answer this question
because there has not been a way to isolate
each of the two pathways (inhalation and
dermal absorption). Previous studies have
measured breath levels due to combined
dermal and inhalation exposure or inhala-
tion exposure only, using a subtraction
method to estimate the dermal contribu-
tion (6,13). We have developed a method
to measure dermal absorption only, as
described below, and applied the method
to bathing in domestic tap water.
Most previous measurements ofhuman
breath concentrations of chloroform to
determine the dose resulting from dermal
or inhalation exposure to tap water have
relied on the use of integrated sampling
methods and subsequent batch analysis.
This has limited the number of samples
that are typically collected in any exposure
study to about four during the uptake phase
and usually no more than about 12 during
the decay phase, thus reducing the reliabili-
tyofdata designed to address these issues.
We have developed new monitoring
technology to obtain better time resolution
over the uptake and elimination periods of
an exposure episode (18,20). The technol-
ogy, which can measure trace VOCs in air
or exhaled breath continuously in real
time, consists of a direct sampling system
(glow discharge ionization source) and a
compact ion trap mass spectrometer
(ITMS) that is capable ofoperation in the
full tandem (MS/MS) mass spectrometric
mode (21-23). For breath analysis, a spe-
cially designed inlet system is attached to
the glow discharge source and provides a
constant flow of exhaled air (18,20). This
direct sampling and analysis approach offers
a powerful means of extracting VOCs
directly from the breath matrix and elimi-
nates the preconcentration step that nor-
mally precedes exhaled air analysis by con-
ventional gas chromatography/mass spec-
trometry (GC/MS) (17,24).
Preliminary work with this equipment
included continuous breath measurements
of one person in an outdoor swimming
pool, as well as measurements of four per-
sons taking hot baths indoors. The person
in the outdoor swimming pool received
almost no exposure through dermal absorp-
tion, although chloroform levels in the
water were 70 pg/l. We therefore had one
subject bathe in cool water (30°C) and then
in hot water (40°C). Breath levels hardly
changed from preexposure levels during the
time in the cool water, but increased
markedly after several minutes at the higher
temperature. These preliminary observa-
tions led us to hypothesize that dermal
absorption is quite limited in water that is
cooler than some value between 30 and
40°C; therefore, we have carried out a set of
experiments to test this hypothesis. Six
additional subjects took baths in chlorinat-
ed water at various temperatures and their
breath levels of chloroform were continu-
ously monitored.
Methods
Exposure Conditions and Breath
Sampling Protocol
The experiments were carried out in two
stages. In the first stage, we used fourvolun-
teers to determine the rate of diffusion of
chloroform through the skin by immersing
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them in a bath containing domestic tap
water at a fixed temperature and measuring
the resulting breath chloroform levels in
real time while isolating them from the
inhalation component ofthe exposure. One
ofthe subjects was also exposed at two dif-
ferent water temperatures. The second stage
made use of six volunteers, each ofwhom
provided breath samples during and after
dermal exposure to chloroform at three
water temperatures. Each subject was fitted
with a face mask (Model 8932; Hans
Rudolph, Inc., Kansas City, MO), equipped
with a two-way nonrebreathing valve set,
which was attached to a purified air supply
to ensure that there was no exposure to
headspace chloroform above the bathtub.
Each subject inhaled clean air through the
first one-way valve and exhaled through the
second valve into the mixing chamber of
the breath inlet system. The fit ofthe mask
was checked for air infiltration before each
experiment by comparing the signal
response with that obtained with zero-grade
air. Information on the subjects and the
conditions in each experiment are provided
in Table 1. The study protocol was
reviewed and approved by the Battelle
Human Subjects Committee, and informed
consent was obtained from each subject.
The subjects were instructed to drink
only bottled water beginning the evening
before the experiment and to refrain from
drinking any bottled beverages, bathing or
showering the morning ofthe experiment,
and using perfumes or after-shave lotions.
Water samples were collected into clean
glass vials with Teflon-lined caps and ana-
lyzed using standard procedures to deter-
mine the concentrations of chloroform in
the water (25). Because the subjects did not
undergo inhalation exposure during the
course of the experiments, no air samples
were collected for analysis.
First stage. For the experiments in the
first stage, a standard bathtub in a bathroom
was filled with tap water and the tempera-
ture adjusted to about40°C. Before entering
the bathroom, the subject changed into a
swimsuit and put on the face mask. The
outlet tube from the face maskwas attached
to the real-time breath analyzer when the
subjectwas in the bathroom and immediate-
ly before he/she stepped into the tub. Upon
providing a preexposure breath sample, the
subject climbed into the bathtub and
immersed him/herself in the water up to
shoulder height. Chloroform breath mea-
surements were made every 6 sec while the
subject continued to breathe purified air.
The water temperature was maintained at
about 400C with a thermocouple gauge,
which was read manually; hot water from
the bathtub faucet was added as needed.
After 20-25 min, when the real-time breath
analyzer indicated that the breath chloro-
form level had reached a plateau, the subject
stepped out of the bathtub and quickly
dried him/herself while continuing to
breathe purified air and exhale into the ana-
lyzer. Postexposure breath measurements
were taken for about 30 min before the sub-
ject was allowed to remove the face mask
and rest in a nearby room. After about 10
min, another brief set of breath measure-
ments were taken for 5-8 min to confirm
that the breath chloroform level was at, or
close to, the original preexposure level.
One of the subjects (subject 4) partici-
pated in a separate experiment that
explored the effect ofwater temperature on
the absorption. The water temperature was
initiallyadjusted to about 300C, and breath
measurements were taken continuously for
about 15 min. Then, the temperature was
raised to about 400C and breath measure-
ments continued for a further 27 min until
the concentration of chloroform in the
breath began to level off.
Second stage. The second set of experi-
ments was carried out in a 380-liter stainless
steelhydrotherapytub (109 cm longx 53 cm
wide x 71 cm high). The tub was connected
to a domestic hot and coldwatersupply and,
immediately before the start of an experi-
ment, the water inflow was adjusted to give
the desired temperature, as indicated by a
digital thermometer (Model 52; Fluke
Corporation, Everett, WA). A water sample
was collected while the subject provided a
preexposure breath sample; the subject then
stepped into the tub and immersed him/her-
self in the water up to neck height.
Chloroform breath measurements were made
every 12 sec while the subject continued to
breathe purified air; readings of the water
temperature were taken manually at regular
intervals throughout the exposure period.
Figure 1 is a schematic ofthe subject in the
filled hydrotherapy tub; the subject wears the
face mask, which is attached to the pure air
supply, and exhales into the breath analyzer.
Measurements at the two lower temperatures
(30 and 35°C) were taken until the breath
chloroform concentrations in each case
appeared to level off before the subject
stepped out ofthe tub. As before, at thehigh-
er temperature (40'C), measurements were
Table 1. Subject characteristics and experimental conditions
Subject l
2
3
4
5
6
7
8
9
10
Sex
M
F
M
F
M
F
M
F
F
M
Height
(cm)
173
180
168
168
168
157
183
170
160
185
Weight
(kg)
81.6
72.6
56.7
52.2
56.7
65.8
79.4
70.3
61.2
102
Age
(year)
35
32
26
26
26
38
23
39
27
23
Chloroform
concentration
in water(pg/I)
91
91
91
81
54.5/78139.5a
86.5/90.5/92.5
89.5/94.5/88
88/93.5/98
101/91/98
-/92.5/93
Water
temperature
(OC)
41
40
40
40
32.4/36.0/39.7.
32.1/35.0/39.6
28.2/34.5138.8
28.8/33.8/38.3
29.5/34.8/38.3
-/35.7/39.0
Exposure
time (min)
24.4
26.9
26.9
27.5
25.4/32.2/21a
30/30/30
30/29.8/29.2
29.2/30/29.8
30/30/29.2
-/29.8/29.6
Abbreviations: M, male, F, female.
Oa/b/cwhere a = value forthe lowtemperature experiment; b = value forthe medium temperature experiment; and c = value forthe high tem-
perature experiment.
Hydrotherapytub
1-Bufe
Pure air
Figure 1. System for sampling exhaled breath samples in real time from a subject exposed by dermal
absorption to pollutants in water.
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taken from the start of the exposure until a
plateau was reached, at which time the sub-
ject climbed out ofthe tub and continued to
exhale into the analyzerwhile breathing puri-
fied air. Postexposure breath measurements
were again taken for about 30 min before the
subject removed the face mask. A second
water sample was collected immediately after
thesubjectstepped outofthetub.
BreathAnalysis
The real-time breath analyzer consists ofthe
breath inlet unit, the direct breath sampling
interface, and the ITMS. Figure 2 shows
the breath inlet attached to the analytical
system (18,20). The mouthpiece and two
one-wayvalves normally used with this unit
were replaced for the work described here
with the Rudolph Model 8932 face mask
(Hans Rudolph, Inc.), which contains a
two-way nonrebreathing valve set, to isolate
the subject from the chloroform in the air.
Purified air for breathing was supplied by a
gas cylinder, and the air was expired via a
large-diameter Teflon tube into a 1.3-liter
glass mixing chamber. The undiluted
breath sample is drawn at a constant rate
from the mixing chamber by the vacuum in
the glow discharge source and flows into
the ionizer at a rate of about 190 ml/min
without anyattention from the subject.
The direct breath sampling interface (Fig.
2) is a glow discharge ionization source,
which is attached to the ITMS. The opera-
tion of this system has been described in
detail elsewhere (26-28). For the work
describedhere, weusedaTeledyne Electronic
Technologies (Mountain View, CA) 3DQ
Discovery ITMS as the analyzer (29). The
3DQ is a compact, field-deployable instru-
ment with high sensitivity and specificity
(21-23). Ions at n/z83 and 47 were selected
as the parent and product ions for chloro-
form, respectively. However, low ion intensi-
ty and limited MS/MS conversion efficiency
(-25%) in the first set ofexperiments pre-
vented us from monitoringfor chloroform in
theMS/MS mode. Instead, wewere forced to
useonlythemolecular ion at n/z83. Because
ofa small contribution present from an inter-
ferent, therewas aslightlyhigherbackground
level than would be expected for breath chlo-
roform under normal conditions (30). Before
undertaking the second set ofexperiments,
the ITMS was modified to reduce thelevel of
background noise from the glow discharge
source (31), and the improvedsignal-to-noise
ratio allowed us to measure chloroform in the
MS/MS mode at m/z 47. This effectively
eliminated the problem due to the interferent
thatwas observed intheinitialexperiments.
To calibrate the real-time breath analyzer
in the laboratory, chloroform gas standards
were prepared in a 186-liter glass chamber.
Figure 2. Continuous breath inlet system attached to direct breath sampling glow discharge source and
iontrap mass spectrometer.
Pure chloroform (0.2 pl) was injected via a
septum into humidified ultra-high purity air
in the chamber at room temperature. Astain-
less steel fan in the chamber blended the stan-
dardwith theair. Humidified ultra-high puri-
ty airwas added to the chamber to dilute the
chloroform concentration to about 100
pg/m3 (21 ppb)-a level slightly above the
maximum breath concentrations expected in
the exposure measurements. Then, 18-liter
and 6-liter samples were taken from the
chamber in Tedlar bags (SKC Inc., Eighty
Four, PA) and evacuated stainless steel canis-
ters, respectively. The two canister samples
were analyzed by a modified EPA method,
TO-14 (34. The concentrations measured in
these analyses were assumed to apply to the
samples in the two Tedlar bags thatwere col-
lectedatthesametimeasthecanistersamples.
To calibrate the breath analyzer for the
exposure experiments in the field, each
Tedlar bag sample was connected to the
sample line at the point where it attached
to the breath inlet unit. In this way, the
calibration gas standards flowed through
the same length of tubing as the actual
breath samples. The ITMS was used to iso-
late the parent or product mass, and the
resultant ion signals were measured at the
two concentrations. The Tedlar bag sam-
ples were used to recalibrate the instrument
immediately before and after breath sam-
pleswere taken from each subject.
DataAnalysis Methods
Percutaneous permeation. Qualitatively,
the breath concentration immediately after
submersion in the bathtub should follow
an S-shaped curve (Fig. 3) with 1) an initial
period To of no change from background
as the chloroform diffuses through the
skin; 2) a period Tj when the concentra-
tion increases in an accelerated way-the
slope goes from zero to a maximum value;
X
E2
U
S
n0
Tome
Figure 3. Key time periods for the flux from the
stratum corneum into the blood and for the con-
centration exhaled in the breath as a function of
time due to dermal exposure from bathing. The
time constant for the flux through the stratum
corneum is sc,. The time to the first measurable
increase in the breath concentration is To. When
the rate of change in the breath concentration is
at a maximum (T1),the flux is assumed to be close
to its asymptote.
and 3) a final period when the concentra-
tion continues to increase but slows to
approach an asymptote-the slope goes
from a maximum value back to zero.
The measured breath uptake curves may
be used to examine the three portions ofthe
S-shaped curve. The first period (To) lasts
from the time the subject is immersed to the
time of the first measurable increase in the
breath concentration. We determined the
value of To bycalculating the standard devi-
ation a ofthe background breath values and
requiringa3a increase overbackground.
Pirot et al. (33) have modeled the stra-
tum corneum (SC) as a homogeneous flat
plate satisfying the diffusion equation
everywhere:
dC(x,t) =-Dd2C
t dx2
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where D is the diffusion coefficient and x
measures the depth ofpenetration into the
SC. From the theory ofheat conduction in
solids, an exact solution to the diffusion
equation for an infinite plate ofthickness L,
where the two sides ofthe plate are held at
two constant temperatures, has been given
by Carslaw andJaeger (34). Replacing tem-
perature with chloroform concentration
and setting the concentration equal to zero
at the inner edge ofthe SC (because ofthe
rapid loss ofchloroform as the blood in the
capillaries removes it from the skin), the
concentration C(x,t) everywhere in the SC
during exposure to a constant chloroform
concentration in thewater Cwa,ris
C(x,t) = PswCwater( 1 -
Dn2, 2t
2 w1nrx
_ PswCwaterX-sin-L e (2)
Here, Psw is the skin-water partition
coefficient. The terms involving time t in
Equation 2 disappear finally, leaving an
equilibrium concentration in the SC
described by a straight line sloping down-
ward from a value ofPswCwat,. at the outer
edge ofthe SC (x = 0) to a value ofzero at
the inner edge (x= L).
The flux across any point x (O<x<L) in
the SC is
-DdC dx x (3)
and the flux into the body (at x= L) during
constant dermal exposure is
-DdC DPw -D-x DPsCwater
dx x=L
Dn2;r2t
C2P~water Lz +2DPsw L cos L~e . 4 L. n=1 L (4)
Finally, assuming that the exposure sud-
denly drops to zero (as the subject leaves
the tub) and that he/she has attained equi-
librium while in the tub, the solution for
the concentration in the SC is given by
2PsC 01 n1 C(x,t)= sw water E -1)
n=1 n(
Dn2g2t
n7tx L2 X sin e Le
L (5)
where tis measured from the time exposure
ends. Differentiation of this expression as
in Equation 3 and evaluation at x = 0 and x
= L provides the flux into and out of the
body after exposure ends. Because more of
the chloroform is contained in the outer
halfofthe SC, more diffuses outward than
into the body; in fact, about two-thirds of
the chloroform in the SC diffuses outward
after the end ofexposure.
Linear compartmental model Although
the theory outlined above provides elegant
solutions for the concentration in and flux
across the SC as a function of the water
concentration, we must still make a connec-
tion between the measured quantity
(exhaled breath) and the observed water
concentration. For this we may turn to a
previously developed simple linear model
(19), with an extension to this case ofder-
mal exposure. The one-compartment model
treats the body as a single compartment. A
very simple way to view the SC is to regard
it as a membrane ofinfinitesimal thickness,
whose only function is to impede the entry
of chloroform into the blood for a certain
lag time T. (This parameter Thas a value
that is similar to the value of To described
above.) Under these conditions, the solu-
tion to the mass-balance differential equa-
tions for exposure to a constant concentra-
tion of chloroform in water is given by
Wallace et al. (19):
Cb th=O (0<t<T) (6)
Cbreath=f'Cwatw,,.(l-e-(t-T)/tuptake) (t>T),(7)
where Cbreath is the chloroform concentra-
tion in the breath; Cwaw,. is the chloroform
concentration in the water; f' is a constant
relating the final equilibrium concentration
in the breath to the concentration in the
water; and tuptke is the effective (uptake)
residence time of the chemical in the body.
Cbreath is the mixed expired air, consisting
both of alveolar air and the portion of the
pure air supply that did not undergo alveo-
lar exchange. (The alveolar concentration
may be calculated from the whole breath
concentration, using a nominal value for
the anatomic dead space volume of the
lungs.) tuptake is expected to be affected
somewhat by the fact that, in reality, the
blood is not experiencing a constant expo-
sure, but rather a rapidly increasing expo-
sure for ashort period immediately after the
first measurable increase. Thus, ruptke will
probably be somewhat larger than the true
residence time . The model has three para-
meters to be determined from the data: f',
T, andtuptae
During the decay phase, the breath
concentration declines exponentially:
Cbreath = Aetldecay, (8)
where t is the time measured from when
exposure ends, A is the breath concentra-
tion when exposure ends, and tk,cay is the
effective residence time in the body during
decay. tc is again expected to be affected
somewhat (i.e., increased over the true resi-
dence time t) by the fact that the exposure
experienced by the blood does not drop
immediately to zero, but falls offat a cer-
tain rate determined by the characteristics
of the SC. If exposure has lasted long
enough to reach equilibrium, then the
value ofAshould be givenbyf'Cwae,,
The two-compartment model assumes a
single metabolizing compartment and a sec-
ond compartment, which is generallyconsid-
ered to includetheorgansorbloodvessel-rich
tissues (19). Again, the solution to continued
exposure at a constant concentration is given
by an initial period ofzero breath concentra-
tion followed by a period ofincreasing con-
centrationtowardanasymptote:
Cbeath
= 0 (O<t<T) (9)
Cbreath = f'Cwater + A1e-(t -T)/c1uptake
+A2e-(t-T)It2uptake (t>T) (10)
where A1, A2 are lumped combinations of
physiological parameters associated with
the first and second body compartments;
and tluptakel r2uptake are the effective
(uptake) residence times ofthe chemical in
the first and second body compartments.
This model has six parameters: f, T, A1,
A2X T1 tuptake, and t2uptake.
The decay phase for the two-compart-
ment model is given by
Cb.rath = A1et e-t1 ecay + A2e-t/'C2decay (11)
Again, if near-equilibrium has been
reached, thenA1 +A2 =fCwatee
All parameters were determined by fit-
ting the background-corrected breath data
using a nonlinear regression technique
(Statgraphics Plus, Manugistics, Inc.,
Rockville, MD; or SigmaPlot Version 3.03,
Jandel Scientific Software, San Rafael, CA).
For the two-compartment model, only the
decayphase was investigated in this way.
These simple models provide useful
heuristic tools for interpreting the data.
There may also be an advantage to apply-
ing physiologically based pharmacokinetic
(PBPK) models to these data, and we plan
to investigate this in futurework.
Background breath concentrations were
determined for each subject before and
after exposure. Ifthe final background con-
centrations were lower than the initial
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Figure 4. Continuous exhaled air concentration of chloroform as E
and following dermal exposure while bathing. (A) For subject 1 (rr
postexposure monitoring ensued for 45.4 min; bathwater chlorofi
water temperature was 41°C. (B) For subject 6 (female), exposur
monitoring ensued for 39 min; bathwater chloroform concentratic
turewas39.6°C.
background, which happened for subjects
1-4, a linear decrease of the background
over that period was assumed. The calcu-
lated background concentrations were then
subtracted from the observed breath con-
centrations to obtain abackground-correct-
ed value. These values were smoothed
before they were finally used to calculate
total exhaled amounts and to fit one- and
two-compartment models.
Results
Multiple measurements ofbreath concentra-
tions were made during and after dermal-
onlyexposure to chloroform in domestic tap
water at three temperatures. Figure 4 shows
the breath chloroform concentration/time
profiles
(male; I
about 4
mal exp
ofbreat]
appears
sion in
of the t
breath 14
a level c
centrati
tion cur
ingsubj
The
and hi1
data po
the sec:
*1S_llil5_|11111sW11ffig111 e, clearly define the critical earlyphases ofthe
uptake and decay curves. Using conven-
tional integrated sampling techniques, it
would be difficult to assign a precise time
when the decay phase begins because in
uptake/decay exposure experiments such as
these, some period oftime typically elapses
-_g oduring the transition of the subjects from
-11 1 the exposed to the nonexposed state. In
this study, however, the subjects were iso-
lated from their immediate environment by
-__ _ _ _ the face mask and they breathed purified
air throughout the entire experiment, so
this problem did not arise.
The uncorrected plots in Figure 4 show
measurements for breath chloroform at lev-
els close to the detection limit ofthe system
(low microgram per cubic meter range),
50 60 70 80 and these weak ion beams give rise to con-
siderable signal noise. There are several fac-
tors that play a role in reducing the mea-
.__ ._...... sured ion signal. Unlike conventional
li31 GC/MS, in which sample preparation
! -, i Ptechniques typically include a sample pre-
_-_E W concentration step and measurement ofthe
GC peak as a compressed plug, the breath
1-_X __ E analyzer used in the present study continu-
ally consumes the compound during the
analysis (35). At relatively constant, low
sample concentrations, the analyte number
density is small and this, in turn, limits the
number of ions that will be formed in the
glow discharge source (28). The ion injec-
tion efficiency into the ion trap from the
glow discharge source has been estimated
_ _ _ _ _ to be no more than 5% under optimum
conditions (36). MS/MS conversion ofpar-
ent ions to product ions further reduces the
50 60 70 80 ion density in the trap by about a factor of
2, and more ion losses occur between the
trap and the detector.
afunction oftimefortwo subjects during To minimize the deleterious effects of
nale), exposure occurred for24.4 min and the scatter on the data from the dermal
orm concentration was 91 pg/1 and bath- absorption ofchloroform at different bath-
e occurred for 30 mi and postexposure watertemperatures, the datawere smoothed n was 92.5 pg/I and bathwater tempera- using a 60-sec blockaveragingtime. Uptake
experiments were conducted at three nomi-
obtained in this way for subjects 1 nal temperatures, 30°C, 35°C, and 40°C,
Fig 4A) and 6 (female; Fig. 4B) at and the results obtained with one male and
0°C. The plots show that, after der- one female subject are presented in Figure
osure commences, the concentration 5A and B. The plots show that the breath
h chloroform rises quite rapidly and levels hardly change from preexposure lev-
to level offafter 10-20 min immer- els during exposure at the low (30°C) tem-
the water. Once the subject steps out perature. The levels are slightly higher at
bathwater and exposure ceases, the the medium (35°C) temperature, with the
evel begins to decrease and returns to male subject (Fig. 5A) showing a somewhat
lose to the original background con- larger increase than the female (Fig. 5B). At
ion. Similar breath uptake/elimina- the high (40°C) temperature, the levels
rves were obtained for all the remain- increase markedly and appear to level offat
jects at400C. about the same maximum values reached
short ion storage times (500 msec) in the experiments conducted at 40°C in
gh sampling frequency (6 sec per the firstphase ofthe study.
int in the first stage and 12 sec in The amount of chloroform exhaled dur-
ond stage) used here allowed us to ing the exposure and postexposure periods
Environmental Health Perspectives * Volume 106, Number 6, June 1998
1
341Articles * Gordon et al.
=
0a
4a
e 00
10 15 20
lime (min)
80
70
60
50
40
30
20
10
10 15 20 Z2
lime(min)
calculated value for the coefficient of the
exponential function (Eq. 7) was 1.067, sug-
gesting that the subjects had reached about
94% oftheir equilibrium value after 30 mmn
exposure. For the decay curve, a two-com-
partment modelappeared to fit the data bet-
ter (adjusted R2 = 0.992) than the one-com-
partment model (adjusted K2 = -0.966);
however, the values forA2 and fi, faled
to reach significance. The one-compartment
fit yielded a residence time tdcay of 7.7 ±
0.37 min (mean ± SE). For the two-com-
partmentfit,AI = 0.91 ± 0.06 (SE) andA2 =
0.1 ± 0.06 (SE), suggesting that about 10%
ofthe total body burden resided in the sec-
ond compartment when exposure ended. In
this case,tldIca = 5.28 ± 0.53 min (SE) and
25 30 35 t2, = 221 ±hv5 mm (SE).
The breath uptake curves at the high
(40°C) temperature were also used to esti-
mate the lag time TO, which is measured
from the time the subject steps into the
water until the blood level of chloroform
rises to a detectable level above background
in the breath, i.e., to the time of the first
measurable increase in the breath concen-
tration. These values are summarized in
Table 3. From these results, the average
time to the first measurable increase is 4.7
± 2.1 min (mean ± SD; range 2-8 min). A
considerable difference in the value of To
was observed for the first group of four
subjects (6.78 ± 1.01 min) compared to the
--t second group of six subjects (2.75 ± 0.57
mi ). The latter value maybe more reliable
because of the improved analytical tech-
30 35 40 45 niques and higher sensitivities available in
the second phase ofthe study.
Figure 5. Effect of water temperature on exhaled air concentration of chloroform plotted as a function of
time for two subjects during dermal exposure from bathing. (A) For subject 5 (male), bath water tempera-
tures and chloroform concentrations were 32.4°C and 54.5 pg/1; 36.0°C and 78 pg/1; and 39.7°C and 39.5
pg/1, respectively (B) For subject 6 (female), bath water temperatures and chloroform concentrations
were 32.11C and 86.5 pg/1, 35.0°C and 90.5 pg/1, and 39.6°C and 92.5 pg/1, respectively. Data for each plot
were smoothed using a 60-sec block averaging time.
was calculated by integrating the area under
the background-corrected curve. A respiration
rate of 9 1/min for males and 7.5 l/min for
females was assumed (37). Results, grouped
by water temperature, are presented for all of
the subjects in Table 2. The mean amount of
chloroform exhaled varied from 0.2 ± 0.3 pg
[mean ± standard deviation (SD)] at the low
(30°C) temperature to 2.3 ± 1.4 pg at the
moderate (35°C) temperature and 7.0 ± 2.0
pg atthehigh (40°C) temperature.
For the one-compartment model, esti-
mates of.f, To} u and r&,cay are sum-
marized in Table 3. All parameter estimates
were highly significant (p<0.01) and R?2 val-
ues were in the range of90%. For the two-
compartment model, estimates ofAl, A2,
Xl&decay and r2dec are also provided in Table
3. Estimates o Al and Tldecay were again
significant (p<0.05) for all subjects, but esti-
mates ofA2 and t2&,cay were significant for
only3 ofthe 10 subjects.
Because ofthe improved analytical tech-
niques for the last six subjects, an attempt
was made to arrive at a single normalized
mean uptake and decay curve for all six (Fig.
6). The mean of the final five breath mea-
surements during the exposure period was
normalized to unity for each subject, and
the initial breath measurement after expo-
sure ended was also set to unity for each
subject. One- and two-compartment fits to
the mean values across all six subjects of
their normalized data were then attempted.
For the uptake curve, only a one-compart-
ment fit, with a residence time tuptake of
10.8 ± 1.0 min [mean ± standard error (SE)]
was acceptable (adjusted I2= 0.968). The
Discussion
The most striking result ofthese studies is
the very strong effect ofbathwater temper-
ature on dermal absorption of chloroform.
The mean exhaled amount of chloroform
increased from 0.2 pg at the lowest bath-
water temperature to 7 pg at the highest
temperature, a factor of about 30. At the
lowest temperatures (28-32°C), virtually
no chloroform was absorbed by four ofsix
subjects, despite a full 25-30 min expo-
sure, and only about 0.5-0.6 pg was
exhaled by the other two. At slightly higher
temperatures (34-36°C), the amount
exhaled increased by an order of magni-
tude, to 2.3 ± 1.4 pg (mean ± SD). At the
highest temperatures used (38-410C), the
amount exhaled increased by another factor
of3, to 7.0 ± 2.0 pg. Similarly, the average
maximum observed breath concentrations
increased from 3 to 19 to 45 pg/m3 for the
three temperature regimes.
We believe the likely explanation for
this effect is the heat-conserving or heat-
dissipating mechanisms ofthe body. At low
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bathwater temperatures, the capillaries clos- different findings all suggest that the tempera- Levesque et al. (13) swimming pool study,
est to the skin surface experience greatly ture/blood flow relationship is paramount in water temperatures were lower, leading to
lessened blood flow. This effectively forces determining dermal absorption. In the first reduced dermal absorption. (Because all the
the chloroform to diffuse across a greater case, all showers were at high temperatures, swimmers in this study were exercising for
distance to reach the blood. Also, the lower leading to a large dermal effect. In the part ofthe time, a study of persons who do
temperature of the SC may cause a lessen-
ing of the speed of diffusion, a process Table2. Exhaled chloroform doseforsubjects in bathwater atthreetemperatures
highly dependent on temperature (38). At Max obs
high bath temperatures, increased blood Water Chloroform Time breath Exhaled
flow to the skin results in a shorter effective temperature concentration in bath conca doseb
diffusion length and an increased speed of Experiments Subject (OC) inwater(pg/I) (min) (pg/mi3) (jig)
diffusion. Ifblood-flow changes to the skin Low temperature 7 28.2 89.5 30 3 0.0
are responsible for these large changes in 8 28.8 88 29.2 0 0.0
dose, we should expect to find tempera- 9 29.5 101 30 1 0.0
ture-related blood-flow changes of at least 4 30 81 15 8 0.6
this orderofmagitude.Infat,measure-6 32.1 86.5 30 2 0.0
this order of magnltude. In fact, measure- 5 32.4 54.5 25.4 5 0.5
ments of blood flow in the extremities have Mean ± SD 30.2 ± 1.6 83.4 ± 14.3 26.6 ± 5.4 3.2 ± 2.7 0.2 ± 0.3
shown even larger factors of 80-600 for Medium temperature 8 33.8 93.5 30 6 0.6
blood flow through the fingers on changing 7 34.5
from a cold to a hot environment (39). 9 34.8
These findings help to explain certain 6 35.0
results obtained in previous studies. For 1 36.0
example, Jo et al. (6) found that for six sub- Mean+SD 35.0+0.7
jects taking 13 showers with andwithout wet High temperature 8 38.3
suits, the amount ofchloroform exhaled dur- 9 38.3
ing normal showers was about twice the 7 38.8
amount exhaled during the showers with wet 10 39.0
suits (inhalation only), suggesting that the 6 39.7
dermal route contributed about 50% ofthe 2 40
total dose. However, a study ofswimmers by 3 40
Levesque et al. (13) found that only about 4 40
25% of the exposure was due to dermal 1 41
absorption. Finally, in a recent study of 4 41
swimmers undergoing rigorous training,
Mean ± SD 39.6 ± 0.9 85
Lindstrom et al. (14) concluded that the der- SD, standard deviation.
rMaximum observed chloroform concentration measured in mixed expired air. mal pathway was responsible for about 75% bCalculated using 9I/min respiration ratefor males and 7.5I/min forfemales.
of the total exposure to chloroform. These
94.5 29.8 30 3.9
91 30 13 1.3
90.5 30 10 1.1
92.5 29.8 30 3.6
78 32.2 25 3.6
0.0 ± 5.5 30.3 ±0.9 19.0 ±9.7 2.3 ± 1.4
98 29.8 30 4.2
98 29.2 60 8.7
88 29.2 45 6.9
93 29.6 70 9.6
92.5 30 70 9.2
39.5 21 45 7.9
91 26.9 20 4.2
91 26.9 32 7.4
81 27.5 41 6.9
91 24.4 43 8.4
81 27.3 38 4.1
i.8 ± 15.6 27.4 ± 2.6 44.9 ± 15.3 7.0 ± 2.0
Table 3. Theoretical calculations of model parameters
Subject
Parameters
Cwamr (ng/ml)
Exposure time (min)
f (x 103)
To(min)9
2Trb
One-compartment model Maximum breath
(uptake and decay) concentration (ng/l)
Uptake
Decay
Residence time (min)
Uptake (ruptake)
Decay (.decayA
Mass excreted (pg)
Two-compartment model Alc
(decay only) A2d 2
c
'ldecayd
T2decay
1 2 3 4 5 6 7 8 9 10
91 91 91 81 39.5 93 88 98 98 93
24.4 26.9 26.9 27.5 21 28 29.2 29.8 29.2 29.6
0.48 0.22 0.35 0.5 1.06 0.70 0.52 0.30 0.65 0.58
7.6 6.6 5.2 7.7 2.4 1.8 3.6 2.8 3.2 2.7
5.7 14 12 15 9.8 27 24 20 20 21
43 20 32 41 42 65 46 29 64 54
32 23 30 42 40 56 40 27 64 69
2.8
8.5
8.4
6.7 6.1 7.1 4.8 13 12 9.6 9.7 10.3
8 7.7 8 8.2 8.6 8.5 7.2 5.6 6.3
4.2 7.4 6.9 8.1 12.3 9.4 6.4 13.1 12.1
17 24 19 31 39 49
22 1.3 11 14 2.2 11
2.9 8.6 5.2 5.9 7.3 6
12.2 12.6 12.4 20 36 24
35 26 63 70
8.9 9.2 2.6 5.3
5.1 2.5 5 4.5
27 22 40 4,5600
Mean ± SD
86.4 ± 16.3
27.3 ± 2.6
0.54 ± 0.24
4.4 ± 2.1
17+7
43.6 ± 13.8
42.3 ± 15.0
8.2 ± 3.1
7.7 ± 1.0
8.8 ± 2.7
37.3 ± 17.2
8.8 ± 6.0
5.3 ± 1.7
22.9 ± 9.6
Abbreviations: Cwater, chloroform concentration in water; f', constant relating equilibrium concentration in breath to concentration in water; To, time from immersion in water to first
measurable increase in breath concentration; c, residence time in Ah body compartment; A, physiological parameter associated with kh body compartment.
8Time to first increase, measured from initial immersion in water until breath concentration shows first measurable increase 13 x standard deviation above background).
tTime required for breath concentration to reach 87% {2X} of maximum value.
cAll AZ and cld.cayvalues are significant.
dOnly subjects 1,4, and 8 had significant A2 andhd,cryvalues.
cS2decayvalue for subject 10 is not included in statistics.
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Figure 6. For subjects 6-10, normalized uptake and decay curves were created by setting each subject's
final breath measurement during exposure and initial breath measurement after exposure equal to unity.
For the uptake portion, only a one-compartment fit was acceptable. For the decay curve, both one- and
two-compartment fits were obtained. (Experimental data were first smoothed using a 60-sec block aver-
aging time; bath watertemperature -400C.)
not exercise in swimming pools would be
expected to produce even less dermal absorp-
tion. We tested one person in a swimming
pool at a temperature of290C and a chloro-
form concentration of70 pg/1 and found no
increase in breath chloroform after 25 min
exposure at low activity). Although the water
temperature in Lindstrom et al.'s (14) experi-
ment was also lower than that of a normal
shower, the rigorous aerobic training had the
same effect as the warmer water temperature
by increasing the internal (core) temperature,
which resulted in greadyincreased blood flow
and therefore in increased dermal absorption.
We can calculate the portion of the
dose that resides in the reservoir ofthe SC
(after equilibrium is attained) by multiply-
ing the average concentration (PswCwater/2
from Equation 5) by the volume ofthe SC.
If 90% of the skin surface (about 16,000
cm2) is in contact with the water and ifthe
average thickness L of the SC is 10 pm,
then the volume of the submerged part of
the SC is 16 cm3 and the mass of chloro-
form in the SC will be 16(PswCwaterl2).
For a skin-water partition coefficient of 10
and a nominal chloroform concentration of
100 pg/l, the amount ofchloroform in the
SC would be 8 pg. Ifthe average thickness
ofthe SC is 25 pm and ifPsw
= 24 [upper
limit noted by McKone (40)], then the
amount in the SC would be 48 pg.
From Equations 1-5, acharacteristic time
;sc(shown in Fig. 3) maybeobtained, with
rsc = L2 (12)
6D.
According to Crank (41), the flux reaches
about 97.5% ofits steady-state value when
t is about 0.45 t5p or roughly L212D. We
have solved the equations exactly, using a
Basic program and carrying out the solu-
tion to 100 terms (10,000 near the singu-
larities ofx = 0, x = L, and t = 0). The solu-
tion shows that rSCcorresponds to the time
in which the flux reaches 0.632 ofthe final
value (see Fig. 3). We presume that the
breath will show its first increase in a time
Tothat is comparable to tsc.
These theoretical considerations can be
connected to the experimentally measured
breath concentration by considering the
rate ofchange ofthe breath concentration,
which occurs in the second portion of the
S-shaped curve described above (compare
Fig. 3). When the flux reaches a maximum,
the rate ofchange ofthe breath concentra-
tion should also reach a maximum. Thus,
To + TI should correspond roughly to
about two to three times the characteristic
time 5cS. However, because of the experi-
mental scatter in the breath data, it is diffi-
cult to determine the time ofthe maximum
slope; TI seems to vary between 2 and 5
min for several subjects, but in some cases
the slope appears to reach a maximum
almost immediately after the first measur-
able rise in the breath concentration. Using
our estimate of 2.75 min for To7 'rsc and
an estimate of To + 2 or To + 5 min for To
+ T7 = 2-3 'rsp we arrive at an estimated
value for 'SC of 2-3 min. Thus, the flux
would reach a near steady-state value after
about 3 ts, or 6-9 min. This value may be
compared to the 12 min estimated from
the model ofMcKone (40) and the 29 min
estimated by an EPA model discussed by
McKone (40).
The third portion of the S-shaped
curve, the time to approach the asymptote,
may be estimated from the single-compart-
ment model uptake residence times tuptake
listed in Table 3. If we use the uptake
model to define the time to reach the
asymptote, we can express this time in
terms of a simple multiple oftuptake, e.g.,
the breath concentration is equal to 87% of
the maximum value at a time correspond-
ing to 2t;Uptake. Applying this condition to
the data in Table 3, the times to reach the
asymptote, also summarized in Table 3, are
between 10 and 27 min for all subjects
except subject 1 (6 min). It should be
noted that these times to reach the breath
asymptote are not the same as the time
required to reach the flux asymptote, as
shown in Figure 3.
The one-compartment model was fitted
to the uptake and decay data for all ofthe
subjects, and values obtained forf', ru take:
and tdecay are presented in Table 3.The
mean residence times for the uptake phase
are quite similar to the times for the decay
phase, namely, tuptake= 8.2 ± 3.1 min
(mean ± SD) and 'tcay= 7.7 ± 1.0 min.
Using the two-compartment model for the
decay phase, the mean residence time for
the first compartment tldeca, is a little
smaller (5.3 ± 1.7 min) than the mean
obtained for the one-compartment model.
However, the estimates of 2dcay were sig-
nificant for only 3 ofthe 10 subjects. These
results suggest that the decay curves for the
two compartments are being obscured by
the continuous diffusion of chloroform
through the SC for a time after exposure
ends. That is, there is not a clear bi-expo-
nential decline as observed in previous
inhalation-only studies (18,19,24,42. This
continued influx would have the effect of
increasing the observed residence time in
the first compartment. So, for example, our
observed times of 6-9 min for the decay
phase are somewhat longer than the times
of 1-7 min obtained for chloroform in
other studies (16,17,42,43). These very
short residence times underscore the
importance ofthe first few minutes imme-
diately following the onset or cessation of
exposure and demonstrate why measure-
ments need to be made with high frequen-
cy in order to determine the true shape of
the uptake and decay curves.
We can relate these theoretical consider-
ations to our observed parameter (exhaled
breath concentration) by noting that the
dose during the exposure must be at least
equal to the total amount of chloroform
exhaled over the measurement period. In
Volume 106, Number 6, June 1998 * Environmental Health Perspectives
1.2
1.0
C
h._
0.8 0
U
aU
._
0
0.8
.0
N0
* O
0.2
0.0
0
344Articles * Temperature effect of dermal exposure to chloroform
fact, since some chloroform is metabolized,
the amount exhaled is only a fraction ofthe
total dose. However, the magnitude ofthis
fraction is not clear. Observations made
with other nonpolar VOCs suggest a range
between 0.1 and 0.3 (19,42).
Conclusions
This study has shown that water tempera-
ture exerts a very strong effect on dermal
absorption of chloroform while bathing.
The study has also successfully demonstrat-
ed the potential of the real-time breath
analyzer for monitoring rapid changes in
concentration that would otherwise be dif-
ficult to detect using more conventional
time-integrated sampling techniques with
standard GC/MS analysis. The technique
has allowed us to determine the time it
takes for chloroform to first appear at a
measurable level in the exhaled breath after
diffusing through the skin during bathing.
It has also provided an estimate of the
resulting breath concentration at near-equi-
librium as a function of the chloroform
concentration and water temperature.
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